The company, which is expected to price its IPO on Thursday evening, now plans to sell 8.3 million shares between $12 and $13 per share.
Audubon, Pennsylvania-based Globus Medical had earlier expected to sell 11.8 million shares in a price range of $16 to $18 per share.
The company, which makes and commercializes products for patients with spine disorders, plans to list its Class A common stock on the New York Stock Exchange under the symbol "GMED".
Globus Medical will sell about 2.1 million shares, while selling stockholders will offer the rest. It intends to use the proceeds from the offering to expand its sales and for investments in research and development.
BofA Merrill Lynch, Goldman Sachs and Piper Jaffray are among the underwriters of the offering.
For the latest updates on the stock market, PRESS CTR + D or visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today
Related Post:
ipo market. stock
- Silver Spring Networks ipo shares prices opened at $22
- Pfizer animal health Zoetis Ipo shares prices
- healthcare realty trust ipo common stock prices
- GlobeImmune ipo stock price
- Astro Malaysia Holding ipo stock price range
- Trulia ipo stock price range and symbol
- Japan Airlines IPO Stock release date september 19 2012
- Japan Airlines IPO stock prices range
- Debut Far East Hospitality Trust 8/27/2012
- Far east hospitality trust ipo stock prices
- Hi-Crush Partner ipo stock prices range
- Manchester United IPO stock predictions
- Bloomin' Brands ipo stock price range
- manchester united ipo prospectus
- Manchester United IPO stock Prices
- five below inc ipo shares prices and stock symbol
- Kayak ipo shares price and stock symbol
- Palo Alto Networks ipo stock symbol and shares prices
- Fender ipo stock symbol and shares prices
- Formula One IPO prospectus Singapore next week
- Speciality Restaurants IPO shares prices, prospectus
- Lantronix IPO file prospectus, shares prices
- LINC Logistics IPO shares prices, stock symbol
- Edgen IPO shares prices, stock symbol
No comments:
Post a Comment